Please do not leave this page until complete. This can take a few moments.
In a move that could ease the issues plaguing many Massachusetts cannabis businesses, Facebook could loosen restrictions on posts promoting marijuana sales.
Valentin Gapontsev, CEO of Oxford laser manufacturer IPG Photonics, lost $1.2 billion of net worth in 2018, according to Forbes' list of billionaires.
Marlborough medical device maker Hologic has been granted approval from three geographic markets since December for a three-in-one hysteroscope.
Acton-based SeaChange International has come to terms on a cooperation agreement with its largest shareholder, which caused CEO Ed Terino to resign.
The Southbridge Tech Incubator, the first Central Mass. South technical co-working space, is now accepting lease applications.
As it prepares its headquarters move to Marlborough, Wayland medical device company Syneron-Candela has rebranded to only Candela.
Calling it a "rapidly growing space," the top securities regulators in Massachusetts on Friday announced the formation of a working group to engage with the financial technology, or fintech, sector.
Revenue at Holliston medical device maker Harvard Bioscience climbed 20 percent last year, with profits rising to $7.4 million, the company said Thursday.
Globoforce, a Framingham workforce software developer, is rebranding.
General Electric's $21-billion sale of its biopharmaceutical division this week could mean changes for GE Healthcare Life Sciences employees in Marlborough and Westborough.
Massachusetts already has a strong digital health market. A new report gives industry leaders pointers for how the state can gain more ground.
Acton insulin pump manufacturer Insulet has reached profitability for the first year in the company's history, reporting $3.3 million in net income as revenues increased 22 percent in 2018.
Edward Terino, CEO of Acton video platform company SeaChange International, is resigning following a dispute with the board of directors regarding a cooperation agreement with a shareholder.
California biologics company LakePharma has launched a viral vector facility in its Gateway Park operations on Worcester Polytechnic Institute's campus.
Marlborough startup drugmaker Phio Pharmaceuticals has changed its name, CEO and model as it attempts to become a cancer therapeutics firm.
Marlborough medtech Boston Scientific is hoping to use a portion of the proceeds from a $4.3-billion offering of senior notes to fund its planned acquisition of U.K. cancer and vascular disease firm BTG.